Evidence map›Paper›PMID 33730255›Full record

Trial reportAIDS and behavior2021

The Hepatitis C Continuum of Care Among HIV-Positive Persons with Heavy Alcohol Use in St. Petersburg, Russia.

Maria A Corcorran, Natasha Ludwig-Baron, Debbie M Cheng, Dmitry Lioznov, Natalia Gnatienko, Gregory Patts, Kaku So-Armah, Elena Blokhina, Sally Bendiks, Evgeny Krupitsky and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Maria A CorcorranDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA. corcom@uw.edu.ORCID http://orcid.org/0000-0002-4935-5166
Natasha Ludwig-BaronDepartment of Epidemiology, University of Washington, Seattle, WA, USA.
Debbie M ChengDepartment of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Dmitry LioznovFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russian Federation.
Natalia GnatienkoDepartment of Medicine, Section of General Internal Medicine, Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, Boston, MA, USA.
Gregory PattsBiostatistics and Epidemiology Data Analytics Center (BEDAC), Boston University School of Public Health, Boston, MA, USA.
Kaku So-ArmahDepartment of Medicine, Section of General Internal Medicine, Boston University School of Medicine/Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, Boston, MA, USA.
Elena BlokhinaFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russian Federation.
Sally BendiksDepartment of Medicine, Section of General Internal Medicine, Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, Boston, MA, USA.
Evgeny KrupitskyFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russian Federation.
Jeffrey H SametDepartment of Medicine, Section of General Internal Medicine, Boston University School of Medicine/Boston Medical Center, Clinical Addiction Research and Education (CARE) Unit, Boston, MA, USA.
Judith I TsuiDivision of General Internal Medicine, Department of Medicine, University of Washington, Seattle, WA, USA.
Boston University · USFirst Pavlov State Medical University of St. Petersburg · RUUniversity of Washington · USBoston Medical Center · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
UNIVERSITY OF WASHINGTON GI TRAINING GRANTT32DK007742 · NIDDK · UNIVERSITY OF WASHINGTON · PI GRADY, WILLIAM MALLORY · 1996 to 2022
$4.7M
URBAN ARCH 4/5 Russia Cohort-Targeting HIV-comorbidities with Pharmacotherapy to Reduce Alcohol and Tobacco Use in HIV-infected RussiansU01AA020780 · NIAAA · BOSTON MEDICAL CENTER · PI FREIBERG, MATTHEW S, SAMET, JEFFREY H. · 2011 to 2021
$4.4M
URBAN ARCH (2/5) Biostatistics and Data Management Core (BDM)U24AA020779 · NIAAA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CHENG, DEBBIE M. · 2011 to 2020
$3.6M
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)U24AA020778 · NIAAA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2011 to 2020
$3.5M
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with BuprenorphineR44DA044053 · NIDA · EMOCHA MOBILE HEALTH, INC. · PI SEIGUER, SEBASTIAN, TSUI, JUDITH · 2017 to 2019
$2.8M
NIAAA NIH HHS U01 AA020780NIAAA NIH HHS U01AA020780, U24AA020779, U24AA020778NIAAA NIH HHS U24 AA020778NIAAA NIH HHS U24 AA020779NIAID NIH HHS P30 AI042853NIDA NIH HHS R44 DA044053NIDDK NIH HHS 5T32DK007742-22NIDDK NIH HHS T32 DK007742Providence/Boston Center for AIDS Research P30AI042853
6 · The paper itself

Abstract

This study describes the self-reported prevalence of hepatitis C virus (HCV) coinfection and the HCV care continuum among persons enrolled in the St PETER HIV Study, a randomized controlled trial of medications for smoking and alcohol cessation in HIV-positive heavy drinkers and smokers in St. Petersburg, Russia. Baseline health questionnaire data were used to calculate proportions and 95% confidence intervals for self-reported steps along the HCV continuum of care. The cohort included 399 HIV-positive persons, of whom 387 [97.0% (95% CI 95.3-98.7%)] reported a prior HCV test and 315 [78.9% (95% CI 74.9-82.9%)] reported a prior diagnosis of HCV. Among those reporting a diagnosis of HCV, 43 [13.7% (95% CI 9.9-17.4%)] had received treatment for HCV, and 31 [9.8% (95% CI 6.6-13.1%)] had been cured. Despite frequent HCV testing in this HIV-positive Russian cohort, the proportion reporting prior effective HCV treatment was strikingly low. Increased efforts are needed to scale-up HCV treatment among HIV-positive Russians in St. Petersburg.

Indexed as

CoinfectionHepatitis CHIV InfectionsContinuity of Patient CareHepacivirusHumansRussiaContinuum of careHepatitis CHIVSubstance use

Identifiers

PMID33730255
PMCPMC8222188
OpenAlexW3139351530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.